Pharma companies making their products more accessible: Study

Divya Rajagopal reports on the 2021 Access to Medicine Index for The Economic Times of India, underlining the pressure of COVID-19 on the large pharmaceutical companies to address research gaps and access to medicine for both COVID-19 and other diseases.

Divya notes the sharp rise in projects in 2020 for the treatment of novel coronavirus, outlining some of the companies' actions to tackle the pandemic. She also draws attention to the low interest in other emerging infectious diseases, especially for low- and middle-income countries.

Read the full article here.